Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
Recruiting
Observational Study
Lung Cancer (Diagnosis)
Osteochondroma
Spitz Nevus
Solid Cancers
Breast Cancer
Gastric (Stomach) Cancer
Colorectal (Colon or Rectal) Cancer
Sarcoma
Ovarian Adenocarcinoma
Uterine Adenocarcinoma
Endometrial Adenocarcinoma
Esophageal Adenocarcinoma
Head and Neck Cancer
Therapy-Related Acute Myeloid Leukemia
Therapy-Related MDS
Clonal Hematopoiesis of Indeterminate Potential (CHIP)
Clonal Cytopenia of Undetermined Significance
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 5,000 (estimated)
- Sponsor
- Dana-Farber Cancer Institute · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of the Clonal Hematopoiesis Chemotherapy and Radiation Effects (CH CARE) Study is to understand how the presence or absence of clonal hematopoiesis (CH) influences outcomes in people receiving chemotherapy and radiation for solid cancers.
The study will collect biospecimens and clinical information. These data will be used to define clinical and molecular features that predict the presen…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Participants to be included in this study include the following:
* Adults age \>18 years
* Diagnosed with solid malignancy (breast, ovarian, lung, gastric, colorectal, esophageal, uterine, head and neck, or sarcoma cancers)
* Have a pending plan to receive chemotherapy or radi…
Contacts
Jenna Beckwith, MPH
CONTACT